WO2006100059A1 - Process for the production of methylcobalamin - Google Patents
Process for the production of methylcobalamin Download PDFInfo
- Publication number
- WO2006100059A1 WO2006100059A1 PCT/EP2006/002635 EP2006002635W WO2006100059A1 WO 2006100059 A1 WO2006100059 A1 WO 2006100059A1 EP 2006002635 W EP2006002635 W EP 2006002635W WO 2006100059 A1 WO2006100059 A1 WO 2006100059A1
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- methylcobalamin
- dimethyl carbonate
- methylation
- cyanocobalamin
- production
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H23/00—Compounds containing boron, silicon, or a metal, e.g. chelates, vitamin B12
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
Definitions
- the present invention relates to a new process for the production of methylcobalamin (I), a coenzyme type vitamin Bi 2 useful in the biosynthesis of methionine and widely employed in medicine for the management of peripheral nervous system diseases.
- Japanese Patent 45038059 discloses the preparation of methylcobalamin (I) by reduction methylation of cyanocobalamin (II) with methyl iodide and sodium borohydride, in the presence of iron salts and the resulting cyano ion is removed.
- German Patent 2,058,892 discloses the preparation of methylcobalamin (I) by methylation of cyanocobalamin reduced with sodium borohydride through methyl p-toluenesulphonate .
- the reaction occurs in the presence of metallic salts (copper or iron) which result in stable complexes with the cyano ion and in the absence of oxygen and light.
- German Patent 2,149,150 discloses the preparation of methylcobalamin (I) by methylation of hydroxocobalamin (II) with methyl mercuric iodide [MeHgI] or ammonium methylhexafluorosilicate [ (NH 4 )SiF 6 Me] .
- German Patent 2,255,203 discloses the preparation of methylcobalamin (I) by methylation and reduction of hydroxocobalamin (III) through oxalic acid methyl monoester and powdered Zn, in the presence of cobalt salts that catalyze the reaction.
- German Patent 2,434,967 discloses the preparation of methylcobalamin (I) by methylation and reduction of cyanocobalamin (II) through methyl acid oxalate and powdered Zn, in the presence of cobalt salts that catalyze the reaction.
- Belgian Patent 889,787 discloses the preparation of methylcobalamin (I) by methylation with methyl iodide after reducing cyanocobalamin (II) with sodium borohydride; the reaction occurs in the presence of an aldehyde in order to sequester the released cyano ion.
- European Patent 1236737 discloses the preparation of methylcobalamin by reduction methylation of cyanocobalamin or hydroxocobalamin through sodium borohydride and trimethylsulfonium or trimethylsulfoxonium halides in the presence of iron or cobalt salts.
- dimethylsulfoxide as a by-product can also occur, which, although non toxic, is not easily removed from the aqueous phase because of its high solubility and high boiling point (189°C) .
- 189°C high boiling point
- the present invention provides a new process for the production of methylcobalamin (I) that comprises using dimethyl carbonate (IV), a non-toxic and environment-friendly reagent, as a methylating agent.
- dimethyl carbonate has arisen as a methylating agent in organic chemistry, especially in the field of the so-called green or sustainable chemistry.
- the advantages of dimethyl carbonate are its innocuousness, low commercial cost and the formation of only carbon dioxide and methanol as by-products.
- dimethyl carbonate due to its poor reactivity and insolubility in water, dimethyl carbonate usually requires anhydrous and vigorous conditions. Working conditions are usually at high temperatures and in strongly basic media.
- dimethyl carbonate despite being an insoluble reagent in water (Merck Index, 13th Edition, #6065), has proved to be an excellent methylating agent of cobalamin Co 1 reduced form (B 12s ) obtained by reduction of either cyanocobalamin (II) or hydroxocobalamin (III) . That is why the so-called supernucleophilic Bi 2s anion is known to be one of the most powerful nucleophilic reagents in organic chemistry (N.N. Greenwood and A. Earnshaw, Chemistry of the elements, Pergamon Press, Oxford, England, 1984, pp. 1321-1322) .
- a major embodiment of the present invention is the production of methylcobalamin (I) by reduction of cyanocobalamin (II) or hydroxocobalamin (III), and subsequent methylation with dimethyl carbonate (IV) :
- R CN : Cyanocobalamin (II)
- R OH : Hydroxocobalamin (III)
- the contribution of the present invention is therefore based on the preparation of methylcobalamin with dimethyl carbonate under non-anhydrous mild conditions, which allow the reaction to be carried out under very selective conditions.
- the methylation reaction occurs in the presence of a reducing agent (V) , in aqueous medium, with or without an organic co-solvent, at nearly ambient temperatures and in slightly basic medium.
- V reducing agent
- methylcobalamin is obtained with a good yield and quality.
- the methylation with dimethyl carbonate does not form byproducts that may give rise to safety, toxicity or environmental problems.
- the amount to be used of dimethyl carbonate can range from 1 to 25 equivalents, but preferably from 3 to 15 equivalents.
- reducing agents (V) those which are capable of reducing the atom of Co(III) to Co(I) can be used, specially hydrides and more specially sodium borohydride .
- the amount to be used of reducing agent (V) is not critical but from 4 to 25 equivalents, preferably from 10 to 20 equivalents are generally employed.
- the reaction temperature can range from 5 to 60 0 C, but a temperature from 20 to 40°C is recommended.
- reaction is carried out in the presence of sequestering agents of cyano ion under standard conditions described in the literature.
- Specially efficient is the use of iron salts, such as ferrous sulfate, and cobalt salts, such as cobalt chloride (II) .
- the amount to be used of sequestering agent of cyano ion is small, usually in the range between 0.1 and 1.0 equivalents, but preferably between 0.2 and 0.5 equivalents.
- the reaction can be carried out by adding sequentially or simultaneously the respective solutions of reducing agent and dimethyl carbonate under the aforesaid conditions.
- the reaction is carried out in aqueous or aqueous- organic medium.
- an organic solvent If an organic solvent is used, its polarity should be enough as to attain solubilization in the aqueous reaction medium.
- alcohols, ketones, ethers, esters, nitriles, amides and ureas preferably alcohols and lower ketones are useful.
- Ci - C ⁇ -alcohols such as methanol, ethanol, n-propanol, i-propanol; ketones such as acetone and methyl ethyl ketone; ethers such as tetrahydrofurane and dioxane; acetonitrile and dimethylformamide.
- reaction is carried out in the absence of oxygen and light in order to avoid the photo-oxidative degradation of methylcobalamin (R. J. Anderson, et al., Journal of Organic Chemistry 1992, 437, 227-337).
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Biochemistry (AREA)
- Biotechnology (AREA)
- Molecular Biology (AREA)
- Genetics & Genomics (AREA)
- Neurosurgery (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Neurology (AREA)
- Animal Behavior & Ethology (AREA)
- Biomedical Technology (AREA)
- Public Health (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Medicinal Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Saccharide Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
Description
Claims
Priority Applications (8)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
BRPI0609125-3A BRPI0609125A2 (en) | 2005-03-23 | 2006-03-22 | process for the production of methylcobalamin |
CA002600987A CA2600987A1 (en) | 2005-03-23 | 2006-03-22 | Process for the production of methylcobalamin |
EP06723627A EP1861415A1 (en) | 2005-03-23 | 2006-03-22 | Process for the production of methylcobalamin |
MX2007011649A MX2007011649A (en) | 2005-03-23 | 2006-03-22 | Process for the production of methylcobalamin. |
AU2006226577A AU2006226577A1 (en) | 2005-03-23 | 2006-03-22 | Process for the production of methylcobalamin |
JP2008502319A JP2008534458A (en) | 2005-03-23 | 2006-03-22 | Method for producing methylcobalamin |
IL185722A IL185722A0 (en) | 2005-03-23 | 2007-09-04 | Process for the production of methylcobalamin |
NO20075211A NO20075211L (en) | 2005-03-23 | 2007-10-11 | Methods for preparing methylcobalamin |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
ES200500703 | 2005-03-23 | ||
ES200500703A ES2264374B1 (en) | 2005-03-23 | 2005-03-23 | METHODCOBALAMINE MANUFACTURING PROCEDURE. |
Publications (1)
Publication Number | Publication Date |
---|---|
WO2006100059A1 true WO2006100059A1 (en) | 2006-09-28 |
Family
ID=36304703
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/EP2006/002635 WO2006100059A1 (en) | 2005-03-23 | 2006-03-22 | Process for the production of methylcobalamin |
Country Status (16)
Country | Link |
---|---|
EP (1) | EP1861415A1 (en) |
JP (1) | JP2008534458A (en) |
KR (1) | KR20070106791A (en) |
CN (1) | CN101175764A (en) |
AR (1) | AR053558A1 (en) |
AU (1) | AU2006226577A1 (en) |
BR (1) | BRPI0609125A2 (en) |
CA (1) | CA2600987A1 (en) |
ES (1) | ES2264374B1 (en) |
IL (1) | IL185722A0 (en) |
MX (1) | MX2007011649A (en) |
NO (1) | NO20075211L (en) |
RU (1) | RU2007139143A (en) |
TW (1) | TW200700430A (en) |
UY (1) | UY29432A1 (en) |
WO (1) | WO2006100059A1 (en) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN102391340A (en) * | 2011-10-31 | 2012-03-28 | 河北玉星生物工程有限公司 | Preparation method of mecobalamin |
Families Citing this family (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2012165934A1 (en) * | 2011-05-30 | 2012-12-06 | Interquim, S.A. De C.V. | Methylcobalamin synthesis process |
CN103113443B (en) * | 2013-02-01 | 2015-02-11 | 山东省医药工业研究所 | Novel chemical synthesis method for preparing mecobalamine |
CN105218608A (en) * | 2015-10-29 | 2016-01-06 | 无锡福祈制药有限公司 | A kind of preparation method of mecobalamin |
CN108948116A (en) * | 2018-08-30 | 2018-12-07 | 上海应用技术大学 | A kind of green synthesis process of Mecobalamin |
CN114874276B (en) * | 2022-04-21 | 2024-06-21 | 南京工业大学 | Improved method for synthesizing mecobalamin |
Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP1236737A1 (en) * | 1999-12-09 | 2002-09-04 | Eisai Co., Ltd. | Process for production of methylcobalamin |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
BE759614A (en) * | 1969-12-01 | 1971-06-01 | Glaxo Lab Ltd | CYANIDE ION REMOVAL FROM CORRINOID SOLUTIONS |
US3928320A (en) * | 1971-11-10 | 1975-12-23 | Jean Boige | Process for the preparation of methylcobalamine |
EP1394174B1 (en) * | 2001-06-05 | 2015-11-11 | Eisai R&D Management Co., Ltd. | Process for producing methylcobalamin |
-
2005
- 2005-03-23 ES ES200500703A patent/ES2264374B1/en not_active Expired - Fee Related
-
2006
- 2006-03-16 TW TW095108911A patent/TW200700430A/en unknown
- 2006-03-17 AR ARP060101046A patent/AR053558A1/en unknown
- 2006-03-21 UY UY29432A patent/UY29432A1/en unknown
- 2006-03-22 MX MX2007011649A patent/MX2007011649A/en not_active Application Discontinuation
- 2006-03-22 RU RU2007139143/04A patent/RU2007139143A/en not_active Application Discontinuation
- 2006-03-22 CN CNA2006800092280A patent/CN101175764A/en active Pending
- 2006-03-22 WO PCT/EP2006/002635 patent/WO2006100059A1/en active Application Filing
- 2006-03-22 EP EP06723627A patent/EP1861415A1/en not_active Withdrawn
- 2006-03-22 JP JP2008502319A patent/JP2008534458A/en not_active Ceased
- 2006-03-22 BR BRPI0609125-3A patent/BRPI0609125A2/en not_active Application Discontinuation
- 2006-03-22 KR KR1020077021782A patent/KR20070106791A/en not_active Application Discontinuation
- 2006-03-22 CA CA002600987A patent/CA2600987A1/en not_active Abandoned
- 2006-03-22 AU AU2006226577A patent/AU2006226577A1/en not_active Abandoned
-
2007
- 2007-09-04 IL IL185722A patent/IL185722A0/en unknown
- 2007-10-11 NO NO20075211A patent/NO20075211L/en not_active Application Discontinuation
Patent Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP1236737A1 (en) * | 1999-12-09 | 2002-09-04 | Eisai Co., Ltd. | Process for production of methylcobalamin |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN102391340A (en) * | 2011-10-31 | 2012-03-28 | 河北玉星生物工程有限公司 | Preparation method of mecobalamin |
Also Published As
Publication number | Publication date |
---|---|
EP1861415A1 (en) | 2007-12-05 |
CA2600987A1 (en) | 2006-09-28 |
AR053558A1 (en) | 2007-05-09 |
BRPI0609125A2 (en) | 2010-02-23 |
UY29432A1 (en) | 2006-06-30 |
IL185722A0 (en) | 2008-01-06 |
RU2007139143A (en) | 2009-04-27 |
ES2264374A1 (en) | 2006-12-16 |
CN101175764A (en) | 2008-05-07 |
JP2008534458A (en) | 2008-08-28 |
NO20075211L (en) | 2007-10-11 |
KR20070106791A (en) | 2007-11-05 |
AU2006226577A1 (en) | 2006-09-28 |
ES2264374B1 (en) | 2007-11-01 |
TW200700430A (en) | 2007-01-01 |
MX2007011649A (en) | 2007-11-14 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
WO2006100059A1 (en) | Process for the production of methylcobalamin | |
EP2045257B1 (en) | Process for producing di(pyrimidine nucleoside 5'-)polyphosphate | |
JP7373598B2 (en) | Method for producing dinucleoside polyphosphate compounds | |
CN112194661B (en) | Preparation method of 4-amino-7-iodopyrrolo [2, l-f ] [ l,2,4] triazine | |
KR100694688B1 (en) | Process for production of methylcobalamin | |
CA3048549A1 (en) | Method for preparing 1,4,7,10-tetraazacyclododecane-1,4,7,10-tetraacetic acid | |
US20240018109A1 (en) | Method for synthesis of roxadustat and intermediate thereof, and intermediate thereof | |
JP4091135B2 (en) | Process for producing substituted 3- (phenylimino) -3H-phenothiazines and phenoxazines | |
JP4358615B2 (en) | Method for producing methylcobalamin | |
US3454559A (en) | Preparation of guanosine and intermediates obtained thereby | |
PT597377E (en) | PROCESS FOR THE RECOVERY OF 3,7-DIALQUILXANTHINS FROM 3-ALKYLXANTHINS | |
CN102127034B (en) | Preparation method of cefozopran side chain acid | |
KR940007418B1 (en) | Process for the preparation of l-ascorbic acid 2-phosphat ester salt derivative | |
CN110078669A (en) | A kind of green synthesis method of loxidazole and its deuterated derivative | |
CN114249667B (en) | Method for preparing N-H ketoamide by two-step one-pot reaction catalyzed by tert-butyl alcohol salt | |
US20010031891A1 (en) | Process for producing perfluoroalkanesulfinate | |
ICHINO et al. | Studies on the Structure of a New Type of Cyclonucleoside, 6, 2'-Triazacyclocytidine | |
KR100351743B1 (en) | Process for preparation of the n,n-dicyclohexyl-2-benzothiazole sulfenamide | |
JPH0952855A (en) | Production of 9-fluorenylmethanols | |
JP4587139B2 (en) | A method for producing an aminoalkoxycarbostyril derivative. | |
CN117561267A (en) | Boric acid compound and method for producing same | |
Krasnokutskaya et al. | 4-Iodoantipyrine synthesized by means of solid-state mechanical activation | |
CN114846018A (en) | Process for producing uridine 5' -diphosphate (UDP), salt thereof or hydrate thereof | |
RU2212406C1 (en) | Method for preparing 6-substituted uracil | |
Kati | 6-Substituted-1, 6-dihydropurine ribonucleosides as inhibitors of adenosine deaminase |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
121 | Ep: the epo has been informed by wipo that ep was designated in this application | ||
WWE | Wipo information: entry into national phase |
Ref document number: 2006226577 Country of ref document: AU |
|
WWE | Wipo information: entry into national phase |
Ref document number: 185722 Country of ref document: IL |
|
WWE | Wipo information: entry into national phase |
Ref document number: 2600987 Country of ref document: CA |
|
WWE | Wipo information: entry into national phase |
Ref document number: 200680009228.0 Country of ref document: CN Ref document number: MX/a/2007/011649 Country of ref document: MX Ref document number: 12007502071 Country of ref document: PH Ref document number: 2006723627 Country of ref document: EP Ref document number: 2008502319 Country of ref document: JP Ref document number: 1020077021782 Country of ref document: KR |
|
NENP | Non-entry into the national phase |
Ref country code: DE |
|
ENP | Entry into the national phase |
Ref document number: 2006226577 Country of ref document: AU Date of ref document: 20060322 Kind code of ref document: A |
|
WWP | Wipo information: published in national office |
Ref document number: 2006226577 Country of ref document: AU |
|
WWE | Wipo information: entry into national phase |
Ref document number: 3750/KOLNP/2007 Country of ref document: IN |
|
WWE | Wipo information: entry into national phase |
Ref document number: 2007139143 Country of ref document: RU |
|
WWP | Wipo information: published in national office |
Ref document number: 2006723627 Country of ref document: EP |
|
ENP | Entry into the national phase |
Ref document number: PI0609125 Country of ref document: BR Kind code of ref document: A2 |